Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

Clinical trial NCT00043316 · COMPLETED

Trial details

NCT number: NCT00043316
Sponsor: InterMune
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2001-02-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.